← Leaderboards
Peter Pebler
Neurobehavioral Systems, Inc.
$2,744,890
Attributed
$5,489,780
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,489,780 · 2
By mechanism
R44$5,489,780 · 2
Top collaborators
- David L Woods9 shared
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposAmericanAffectTrainingCognitiveMedicalParticipantNovel TherapeuticsInnovationManualsDementiaCostImpaired CognitionDesignS DiseaseCaliforniaCognitive TestingClinical TrialsComputerizedBenchmarkingCognitionSpeechPerformanceMaterials Testing
Grant awards (9)
At-home computerized assessment of normal cognitive aging and age-related cognitive decline in older African Americans, Hispanics, and rural non-Hispanic whites$833,800
R44 · FY2025 · AG
At-home computerized assessment of normal cognitive aging and age-related cognitive decline in older African Americans, Hispanics, and rural non-Hispanic whites$831,176
R44 · FY2024 · AG
At-home computerized assessment of normal cognitive aging and age-related cognitive decline in older African Americans, Hispanics, and rural non-Hispanic whites$497,122
R44 · FY2022 · AG
Computerized tests of cognitive decline in presymptomatic Alzheimerâs disease$250,000
R44 · FY2022 · AG
Computerized tests of cognitive decline in presymptomatic Alzheimer's disease$848,084
R44 · FY2021 · AG
Computerized tests of cognitive decline in presymptomatic Alzheimer's Disease$916,952
R44 · FY2020 · AG
Computerized tests of cognitive decline in presymptomatic Alzheimerâs disease$202,318
R44 · FY2020 · AG
Computerized tests of cognitive decline in presymptomatic Alzheimer's disease$680,188
R44 · FY2019 · AG
Computerized tests of cognitive decline in presymptomatic Alzheimerâs disease$430,140
R44 · FY2018 · AG